A 1-Year Follow-Up Retrospective Study

Alessandro Minniti,Marino Caroprese,Morris Zarantonello,Daniele De Santis,Gialfonso Caliendo,Federico Gelpi
DOI: https://doi.org/10.3390/jcm13102954
IF: 3.9
2024-05-18
Journal of Clinical Medicine
Abstract:Background: In this multicenter case series analysis, the authors present successful instances of 20 single-screw-retained and implant-supported prosthetic rehabilitation samples. Methods: A high-density heterologous dermal matrix (Derma® Osteobiol by Tecnoss, Torino, Italy) was employed with a specific technique named the matrix tissue graft (MTG) in all these cases characterized by an inadequate initial supra-crestal tissue height (thin if 1 mm or medium if 2 mm) to enhance the peri-implant soft tissues both vertically and horizontally. Results: The implants were deemed successful in all cases, yielding a success proportion of 100% (one-sided 97.5% confidence interval = 83.2–100%). The buccal and lingual gains were, respectively, 2.2 ± 0.38 mm (range 1.7–3.22 mm) and 0.83 ± 0.33 mm (range 0.1–1.5 mm). These measurements were calculated as the maximum distance between two superimposed .stl file models (derived from two different IOS devices) scanned before implant placement and 1 year after dermal matrix healing. Conclusions: An outstanding vertical and horizontal gain was obtained using this heterologous derma matrix placed above the bone crest and surrounding the dental implants.
medicine, general & internal
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to evaluate the effectiveness and stability of using high - density dermal matrix (Derma®Osteobiol by Tecnoss, Torino, Italy) for soft - tissue augmentation surgery in dental implant applications. Specifically, the objective of the study is to achieve the best soft - tissue augmentation effect by using a dermal matrix through an innovative technique while maintaining a less - invasive surgical approach within a 1 - year follow - up period. The key issues mentioned in the paper include: - **Soft - tissue deficiency**: Many patients have insufficient soft - tissue height above the alveolar ridge, which affects the function and aesthetic effect of implant - supported restorations. - **Limitations of existing methods**: Traditional autologous or allogeneic transplantation methods have some limitations, such as donor - site damage, surgical complexity, and high invasiveness. - **Application of new technology**: The study introduced a new high - density dermal matrix material and its application technology, aiming to reduce the invasiveness of the surgery and improve the effect of soft - tissue augmentation. Through this study, the author hopes to verify the effectiveness of this new material and technology and provide clinicians with a new and more effective method for soft - tissue management.